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Abstract
H7 subtype influenza viruses represent a persistent public health threat because of their continued 
detection in poultry and ability to cause human infection. An outbreak of highly pathogenic avian 
influenza H7N7 virus in Italy during 2013 resulted in 3 cases of human conjunctivitis. We 
determined the pathogenicity and transmissibility of influenza A/Italy/3/2013 virus in mouse and 
ferret models and examined the replication kinetics of this virus in several human epithelial cell 
types. The moderate virulence observed in mammalian models and the capacity for transmission in 
a direct contact model underscore the need for continued study of H7 subtype viruses.
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The emergence of human infection with low-pathogenicity avian influenza (LPAI) A(H7N9) 
viruses in 2013 and their continued detection in humans to date has highlighted the 
pandemic potential of the H7 subtype [1]. However, unlike the severe respiratory disease 
frequently detected among most human cases of A(H7N9) infection, human infection 
associated with other influenza viruses within the H7 subtype has typically consisted of 
ocular disease; >80% of confirmed or presumed H7 human infections between 1996 and 
2012 have presented with conjunctivitis [2]. The largest such outbreak occurred in 2003 and 
was caused by high-pathogenicity avian influenza (HPAI) A(H7N7) virus in the 
Netherlands, with >80 cases of conjunctivitis reported following occupational exposure [3]. 
More recently, an HPAI A(H7N3) outbreak in Jalisco, Mexico, in 2012 resulted in 2 cases of 
human conjunctivitis [4]. While most influenza viruses outside the H7 subtype do not 
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display an ocular tropism, there remains a need to investigate viruses that cross the species 
barrier to cause human infection, regardless of the severity of their clinical presentation.
In August and September of 2013, an outbreak of HPAI A(H7N7) virus in the Emilia-
Romagna region (Ferrara and Bologna provinces) of Italy resulted in the depopulation and 
culling of approximately 1.5 million birds [5]. Three polymerase chain reaction–confirmed 
A(H7N7) infections were reported among individuals who had direct contact with infected 
poultry, all of whom presented with conjunctivitis; symptoms resolved in the absence of 
antiviral treatment [5, 6]. Two additional asymptomatic individuals directly involved in 
culling activities were subsequently identified to be seropositive for A(H7N7) [7]. These 
cases represent the first evidence of human infection with H7 viruses in Italy since 2002–
2003, when 7 individuals exhibited serologic evidence of H7 infection following outbreaks 
of LPAI H7N3 virus in Brescia and Verona provinces [8]. A subsequent outbreak of HPAI 
A(H7N7) infection in the Emilia-Romagna region in April and May of 2016, resulting in the 
death or destruction of >66,000 birds [9], further underscores the importance of studying the 
capacity of H7 viruses to infect and spread between mammals. Here, we examined in two 
mammalian models the pathogenicity and transmissibility of an HPAI A(H7N7) virus (A/
Italy/3/2013 [hereafter, “Italy/3 virus”]) isolated from a human conjunctival swab specimen 
and investigated the capacity of Italy/3 virus to replicate in several human cell types.
METHODS
Virus
Italy/3 virus was propagated in the allantoic cavity of 10-day-old embryonated hen’s eggs at 
37°C for 26 hours. Allantoic fluid pooled from multiple eggs was clarified by centrifugation 
and frozen in aliquots at −70°C until use. Determination of infectious titer as 50% egg 
infectious doses (EID50) or plaque-forming units (PFU) in Madin-Darby canine kidney 
(MDCK) cells was calculated as previously described [10, 11]. All experiments were 
conducted under biosafety level 3 containment, including enhancements as required by the 
US Department of Agriculture and the National Select Agent Program [12].
Mouse Studies
Female BALB/c mice (8 weeks of age) were anesthetized with 2,2,2-tribromoethanol in tert-
amyl alcohol (Avertin; Sigma-Aldrich) and inoculated intranasally with 106 PFU/50 µL of 
virus [13]. Five mice per group were monitored daily for morbidity (measured by weight 
loss) and mortality for 14 days after inoculation. Three mice per group were euthanized on 
days 3 and 6 after inoculation, and lung, nose, and brain tissue specimens were collected and 
titrated by standard plaque assay in MDCK cells [10]. The 50% mouse infectious dose and 
50% mouse lethal dose were determined as previously described [11]. Briefly, mice were 
inoculated with 10-fold serial dilutions of virus; 5 mice per dilution were observed daily for 
morbidity and mortality, and 3 mice per dilution were euthanized on day 3 after inoculation, 
lungs were titered by standard plaque assay, and the infectious dose was determined by the 
method of Reed and Muench. All animal procedures were approved by the Institutional 
Animal Care and Use Committee of the Centers for Disease Control and Prevention and 
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were conducted in an Association for Assessment and Accreditation of Laboratory Animal 
Care International–accredited facility.
Ferret Studies
Male Fitch ferrets (Triple F Farms), 7 months of age and seronegative for currently 
circulating influenza viruses, were housed in cages within a Duo-Flow Bioclean 
environmental enclosure (Lab Products). Ferrets were inoculated intranasally with 106 
EID50/mL of virus and monitored daily for clinical signs and symptoms of infection. 
Transmission of virus to naive ferrets in the presence of direct contact was performed as 
previously described [14]. Nasal washes (from both inoculated and contact ferrets), 
conjunctival washes (from inoculated ferrets only), and rectal swabs (from inoculated ferrets 
only) were collected on alternate days after inoculation and titrated by serial dilution in eggs 
as previously described [14]. Three additional ferrets were inoculated with virus and 
euthanized on day 3 after inoculation for the assessment of virus replication and systemic 
spread, as previously described [13]. Seroconversion of contact ferrets to homologous virus 
was assessed on day 23 after contact by a standard hemagglutination inhibition assay with 
1% turkey red blood cells, as previously described [15].
In Vitro Replication Kinetics
Primary human nasal epithelial cells (PromoCell), alveolar epithelial cells (CellBiologics), 
or corneal epithelial cells (ATCC) were grown to confluence in transwell inserts (Corning), 
infected apically in triplicate with virus at a multiplicity of infection (MOI) of 0.01 for 1 
hour, washed, and incubated at 37°C in the presence of exogenous TPCK trypsin. The 
bronchial epithelial cell line Calu-3 (ATCC) was infected similarly to primary cells and 
incubated at either 37°C or 33°C after infection, without the addition of TPCK trypsin [10]. 
Aliquots of culture supernatant were removed at indicated times after inoculation, and titers 
of infectious virus were determined by standard plaque assay in MDCK cells.
RESULTS
Eurasian lineage HPAI H7 viruses typically replicate to high titer in the murine respiratory 
tract without prior adaptation, causing moderate-to-severe morbidity when mice are 
inoculated at high doses [13]. Mice inoculated with Italy/3 virus exhibited moderate weight 
loss but no mortality (Table 1), in agreement with the lack of the mammalian host adaptation 
marker E627K in the PB2 gene of Italy/3 virus [6]. Viral titers in the nose and lung on days 
3 and 6 after inoculation were robust and generally comparable to those of other Eurasian-
lineage H7 subtype viruses. The 102.8 PFU 50% mouse infectious dose for this virus is 
generally analogous to those observed for other Eurasian lineage H7N7 viruses, indicating 
that this virus may possess similar infectivity as compared to other viruses within this 
subtype [13].
Owing to the close physiologic similarity of human and ferret respiratory tracts and similar 
presentation of signs and symptoms of infection, ferrets represent the best small-mammalian 
model to study the pathogenicity and transmissibility of influenza viruses [16]. Ferrets 
inoculated with Italy/3 virus exhibited a generally mild infection, with low and transient 
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weight loss and fever detected early after infection (Table 1). Despite the limited morbidity 
observed in infected ferrets, virus replicated to high titers throughout the upper and lower 
respiratory tract, including the lung. Low viral titers were found in rectal swabs of all 
inoculated ferrets and in intestinal tissue of 1 of 3 ferrets. Virus was further detected in the 
olfactory bulb and anterior brain of 2/3 ferrets. Italy/3 virus was present in conjunctival 
washes from 1 of 3 ferrets observed throughout the acute phase of infection but was not 
detected in the eye or surrounding conjunctiva from ferrets scheduled for postmortem 
necropsy on day 3 after inoculation (Table 1; data not shown), similar to what was observed 
following ferret inoculation with HPAI H7N3 virus associated with ocular disease in humans 
[14]. Overall, the distribution and magnitude of viral titers were generally in accord with 
those of other low-to-moderately virulent H7 viruses in the ferret model [13, 14, 17].
H7 viruses of both Eurasian and North American lineages associated with human 
conjunctivitis have been shown to demonstrate limited virus transmissibility in the presence 
of direct contact. To determine whether Italy/3 virus shared this property, we placed naive 
ferrets in direct contact with virus-inoculated ferrets 24 hours after inoculation and collected 
nasal washes from both inoculated and contact ferrets on alternate days to assess virus 
transmissibility (Figure 1A). Ferrets inoculated with Italy/3 virus shed detectable virus in 
nasal washes at titers of >104 EID50 through day 5 after inoculation, typical of avian 
influenza viruses in this model. One of 3 ferrets placed in direct contact shed virus with 
comparable kinetics and titer as inoculated ferrets and seroconverted to homologous virus; a 
second ferret seroconverted but did not shed detectable virus (Figure 1A and data not 
shown). These results indicate that, similar to other HPAI H7 viruses associated with human 
conjunctivitis, Italy/3 virus possesses a capacity to transmit virus in a direct contact ferret 
model, albeit inefficiently.
The detection of infectious virus in both upper and lower respiratory tract tissues of ferrets 
prompted us to determine the capacity of Italy/3 virus to replicate in epithelial cells 
distributed throughout the human respiratory tract, as well as the eye. While the receptor 
binding profile of Italy/3 virus has not been determined, previous Eurasian-lineage A(H7N7) 
viruses associated with human infection have maintained strong binding to α2–3 linked 
sialic acids [15]. To examine differences in tissue tropism, we infected 3 primary human cell 
types with Italy/3 virus: nasal, alveolar, and corneal epithelial cells (Figure 1B). Italy/3 virus 
exhibited productive replication in all cell types; peak titers of >104 PFU/mL were detected 
48–72 hours after inoculation in nasal epithelial and corneal epithelial cells, and peak titers 
of >103 PFU/mL were detected in alveolar epithelial cells 48 hours after inoculation. Robust 
replication was further observed in the human bronchial epithelial cell line Calu-3 (Figure 
1C), with viral titers reaching >107 PFU/mL by 48 hours after inoculation when cultured at 
37°C and virus exhibiting a temperature sensitivity at 33°C that is common among avian 
influenza viruses [17, 18]. These results demonstrate that, similar to other avian influenza 
viruses, Italy/3 virus is capable of replicating in upper respiratory tract, lower respiratory 
tract, and ocular epithelial cell types that possess differing distributions of terminal sialic 
acids on their cell surface.
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DISCUSSION
HPAI H7 influenza viruses of both Eurasian and North American lineages continue to cause 
infrequent outbreaks in poultry, resulting in extensive depopulations of infected and at-risk 
birds, profound economic losses, and potential occupational exposures of individuals 
involved with outbreak control. Over 80 distinct outbreaks of HPAI and/or LPAI H7 virus in 
poultry have been reported to the World Organization for Animal Health in the past decade 
worldwide, highlighting the pandemic potential of this virus subtype and the potential for 
human infection to occur as a result of occupational exposure during culling and 
depopulation activities. While H7 viruses have not demonstrated sustained human-to-human 
transmissibility, clusters of limited transmission among close contacts with both HPAI 
A(H7N7) and LPAI A(H7N9) viruses has emphasized the need to monitor the ability of H7 
viruses to acquire this property [1, 3]. Furthermore, while all in vivo experiments were 
conducted following traditional intranasal virus inoculation, it is likely that, similar to other 
human and avian influenza viruses tested in the ferret model, Italy/3 virus would maintain 
infectivity following ocular exposure [19, 20]. The mammalian pathogenicity and 
transmissibility of the HPAI A(H7N7) Italy/3 virus appears to be generally comparable to 
observations for other HPAI H7 viruses from both lineages associated with human 
conjunctivitis, underscoring the need to monitor influenza viruses for which conjunctivitis is 
the primary manifestation of disease.
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Figure 1. 
Replication of influenza Italy/3 virus in vivo and in vitro. A, Three ferrets were inoculated 
with 106 50% egg infectious doses (EID50) of Italy/3 virus, and nasal washes were collected 
from each ferret on the indicated days after inoculation (left bars) to assess viral replication. 
A naive ferret was placed in the same cage as each inoculated ferret at 24 hours after 
inoculation, and nasal washes were collected from each contact ferret on the indicated days 
after contact (right bars). The limit of virus detection was 101.5 EID50/mL. Seroconversion 
to homologous virus was detected in the first and third ferret contact pairs shown on day 23 
after contact. B, Primary human nasal epithelial, alveolar epithelial, or corneal epithelial 
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cells were infected apically with Italy/3 virus at a multiplicity of infection of 0.01 for 1 hour, 
washed, and incubated at 37°C. Viral titers were determined at the indicated times. The limit 
of virus detection was 10 plaque-forming units (PFU)/ mL. The mean value (+SD) from 
triplicate independent cultures per virus is shown. C, Calu-3 cells were infected similarly to 
primary cells and incubated at 37°C or 33°C. Supernatants were removed at indicated times 
after inoculation, and titers of infectious virus were determined by standard plaque assay at 
the indicated times. The limit of virus detection was 10 PFU/mL. The mean value (+SD) 
from triplicate independent cultures per virus is shown.
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Table 1
Characteristics of Influenza A/Italy/3/13 Virus Infection in Mice and Ferrets
Variable Value
Mice
  MID50, PFU/50 µL 102.8
  MLD50, PFU/50 µL >106
  Maximum percentage weight loss, meana 14.2
  Virus titer, log10 PFU/mL, by time after infectionb
    3 d
     Nose 3.0 ± 0.6
     Lung 5.6 ± 0.2
    6 d
     Nose 3.4 ± 1.9
     Lung 6.3 ± 0.1
Ferretsc
  Maximum percentage weight loss, mean 4.6
  Maximum increase in body temperature, °C, meand 1.2
  Virus detected in CW, proportion 1/3
  Virus detected in RS, proportion 3/3
  Virus titer 3 d after infection, log10 EID50/mLe
    Nasal turbinates 7.5 ± 0.3
    Trachea 5.3 ± 0.6
    Lung 4.1 ± 1.8
    Olfactory bulb 3.1 ± 0.2
    Brain 3.3 ± 1.0
    Intestine 2.8
Data are mean ± SD, unless otherwise indicated.
Abbreviations: CW, conjunctival washes; MID50, 50% mouse infectious dose; MLD50, 50% mouse lethal dose; PFU, plaque-forming units; RS, 
rectal swabs.
a
Data are from d 7 after infection.
b
Data are from 3 animals per group. The limit of virus detection was 10 PFU.
c
Data are from 2 d after infection, for weight loss; 1–2 d after infection, for fever; 1 and 3 d after infection, for virus detection in CW; 3 and 5 d 
after infection, for virus detection in RS; and 3 d after infection, for virus titers.
d
Baseline body temperature range, 38.6°C–38.9°C.
e
Data for nasal turbinates, trachea, and lung are from 3 of 3 ferrets, data for olfactory bulb and brain are from 2 of 3 ferrets, and data for intestine 
are from 1 of 3 ferrets. The limit of virus detection was 101.5 EID50/mL.
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